A cluster randomised trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease

Alberta Heritage Foundation for Medical Research (Canada)0 个研究点目标入组 160 人开始时间: 2005年6月14日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•Patients with HF or IHD who are not currently taking the study medications of interest (Angiotensin-Converting Enzyme [ACE] inhibitors/angiotensin receptor blockers for HF or statins for IHD), and whose primary care physician of record is part of the study. For patients who happen to be eligible for both HF and for IHD, only one condition will be selected at random.

•1. Decline enrolment
•2. Unable or unwilling to give informed consent
•3. Have previously taken the study medications according to dispensing records
•4. Have a documented allergy or intolerance to study medications according to pharmacist records
•5. Are in long-term care facilities or institutions
•6. Do not confirm on the basis of self-report that they have a diagnosis of either HF or IHD
•7. Primary care physician has already contributed 5 patients to the study

发起方

Alberta Heritage Foundation for Medical Research (Canada)